Differentiating Ewing's sarcoma from other diseases: Difference between revisions
Jump to navigation
Jump to search
Mahshid |
Ahmed Younes (talk | contribs) No edit summary |
||
| Line 1: | Line 1: | ||
__NOTOC__ | __NOTOC__ | ||
[[Image:Home_logo1.png|right|250px|link=http://www.wikidoc.org/index.php/Ewing%27s_sarcoma]] | |||
{{CMG}};{{AE}} {{PSK}}; '''Assistant Editor(s)-In-Chief:''' [[User:Michael Maddaleni|Michael Maddaleni, B.S.]] | {{CMG}};{{AE}} {{PSK}}; '''Assistant Editor(s)-In-Chief:''' [[User:Michael Maddaleni|Michael Maddaleni, B.S.]] | ||
Latest revision as of 22:29, 20 February 2019
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1];Associate Editor(s)-in-Chief: Suveenkrishna Pothuru, M.B,B.S. [2]; Assistant Editor(s)-In-Chief: Michael Maddaleni, B.S.
Overview
Ewing's sarcoma must be differentiated from osteosarcoma, hematological malignancy, eosinophilic granuloma, and malignant fibrous histiocytoma.[1]
Differentiating Ewing's sarcoma from other diseases
Ewing's sarcoma must be differentiated from:[1]
- ALP is not elevated in Ewing sarcoma.
- Ewing sarcoma tends to arise from the diaphysis whereas in osteosarcoma it tends to arise from the metaphysis.
- Osteomyelitis
- Hematological malignancy
References
- ↑ 1.0 1.1 Ewing's sarcoma. Dr Amir Rezaee◉ and Dr Frank Gaillard◉ et al.Radiopaedia.org 2015. http://radiopaedia.org/articles/ewing-sarcoma